Skip to main content

Table 1 Presence of a code for CMV-associated conditions a among all infants, infants with CMV-specific testing, infants with non-specific testing, and infants with a diagnostic code for CMV, MarketScan 2011 b

From: Laboratory testing and diagnostic coding for cytomegalovirus among privately insured infants in the United States: a retrospective study using administrative claims data

CMV-associated conditiona

All Infants

Infants with CMV-specific testingc

Infants with Non-specific testingd

Infants with an ICD-9-CM code for congenital CMV infection or CMV disease

N=368,266

N=229

N=1,091

N=61

# (%)

# (%)

# (%)

# (%)

Chorioretinitis

13 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Encephalitis

12 (0.0)

0 (0.0)

3 (0.3)

0 (0.0)

Hepatomegaly

45 (0.1)

5 (2.2)

1 (0.1)

0 (0.0)

Jaundice

110,997 (30.1)

54 (23.6)

361 (33.1)

11 (18.0)

Low Birth Weight

33,933 (9.2)

139 (60.7)

266 (24.4)

24 (39.3)

Microcephaly

115 (0.0)

5 (2.2)

7 (0.6)

3 (4.9)

Other Congenital Anomalies of Nervous System

988 (0.3)

24 (10.5)

28 (2.6)

4 (6.6)

Petechiae

1,650 (0.5)

1 (0.4)

2 (0.2)

1 (1.6)

Seizures

1,057 (0.3)

21 (9.2)

55 (5.0)

4 (6.6)

Splenomegaly

10 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Thrombocytopenia

1,120 (0.3)

36 (15.7)

40 (3.7)

5 (8.2)

Any of the above 11 CMV-associated conditions

136,857 (37.2)

187 (81.7)

599 (54.9)

37 (60.7)

None of the above 11 CMV-associated conditions

231,409 (62.8)

42 (18.3)

492 (45.1)

24 (39.3)

  1. aSee Additional file 1: Table S1 for ICD-9-CM and CPT codes used to identify CMV-associated conditions.
  2. bInfants are defined as enrollees ≤ 1 month of age with ≥1 medical claim within 30 days of a newborn code (defined as either a code for live birth, or observation and evaluation of newborns and infants; codes defined in Additional file 1: Table S1).
  3. cCMV-specific testing includes CMV serologic testing (CMV IgG, CMV IgM, and CMV EIA), CMV DFA, and CMV PCR testing. (See Additional file 1: Table S1 for CPT codes).
  4. dNon-specific testing includes viral culture, molecular diagnostics, or infectious agent detection. (See Additional file 1: Table S1 for CPT codes).